[go: up one dir, main page]

BRPI0507312A - derivados de quinolina para uso como inibidores micobacterianos - Google Patents

derivados de quinolina para uso como inibidores micobacterianos

Info

Publication number
BRPI0507312A
BRPI0507312A BRPI0507312-0A BRPI0507312A BRPI0507312A BR PI0507312 A BRPI0507312 A BR PI0507312A BR PI0507312 A BRPI0507312 A BR PI0507312A BR PI0507312 A BRPI0507312 A BR PI0507312A
Authority
BR
Brazil
Prior art keywords
quinoline derivatives
mycobacterial
inhibitors
mycobacterial inhibitors
useful
Prior art date
Application number
BRPI0507312-0A
Other languages
English (en)
Inventor
Jerome Emile George Guillemont
Elisabeth Ther Se Jea Pasquier
David Francis Alain Lancois
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of BRPI0507312A publication Critical patent/BRPI0507312A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)

Abstract

DERIVADOS DE QUINOLINA PARA USO COMO INIBIDORES MICOBACTERIANOS. A presente invenção refere-se a derivados de quinolina substituídos de acordo com a fórmula geral (l) úteis no tratamento de doenças micobacterianas tal como TB.
BRPI0507312-0A 2004-01-29 2005-01-28 derivados de quinolina para uso como inibidores micobacterianos BRPI0507312A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04075286 2004-01-29
PCT/EP2005/050375 WO2005075428A1 (en) 2004-01-29 2005-01-28 Quinoline derivatives for use as mycobacterial inhibitors

Publications (1)

Publication Number Publication Date
BRPI0507312A true BRPI0507312A (pt) 2007-06-26

Family

ID=34833674

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0507312-0A BRPI0507312A (pt) 2004-01-29 2005-01-28 derivados de quinolina para uso como inibidores micobacterianos

Country Status (20)

Country Link
US (1) US7790894B2 (pt)
EP (1) EP1713776B1 (pt)
JP (1) JP4919810B2 (pt)
KR (1) KR101160183B1 (pt)
CN (1) CN1910154B (pt)
AP (1) AP2321A (pt)
AT (1) ATE395336T1 (pt)
AU (1) AU2005210036B2 (pt)
BR (1) BRPI0507312A (pt)
CA (1) CA2554049C (pt)
DE (1) DE602005006744D1 (pt)
EA (1) EA011572B9 (pt)
ES (1) ES2306098T3 (pt)
IL (1) IL177101A (pt)
MX (1) MXPA06008596A (pt)
NO (1) NO337253B1 (pt)
NZ (1) NZ547614A (pt)
UA (1) UA83875C2 (pt)
WO (1) WO2005075428A1 (pt)
ZA (1) ZA200606291B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2855B1 (en) 2005-08-03 2015-03-15 شركة جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
JO3271B1 (ar) 2006-12-06 2018-09-16 Janssen Pharmaceutica Nv مشتقات الكوينولين المضادة للجراثيم
JO2970B1 (en) 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2684B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان في Quinoline antibacterial derivatives
JO2683B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2685B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان في Quinoline antibacterial derivatives
WO2010083436A1 (en) 2009-01-15 2010-07-22 Rutgers, The State University Of New Jersey Benzo [c] phenanthridines as antimicrobial agents
WO2010127307A1 (en) 2009-04-30 2010-11-04 Rutgers, The State University Of New Jersey Antimicrobial agents
US8933096B2 (en) 2010-06-09 2015-01-13 Rugers, The State University of New Jersey Antimicrobial agents
WO2011163610A2 (en) * 2010-06-25 2011-12-29 Rutgers, The State University Of New Jersey Antimicrobial agents
RU2486175C2 (ru) * 2011-09-12 2013-06-27 Закрытое Акционерное Общество "Фарм-Синтез" Производные хинолина, в частности 5,6,7-замещенные 1-(2-хлорхинолин-3-ил)-4-диметиламино-2-(нафталин-1-ил)-1-фенилбутан-2-олы, способ получения и применение соединений
US9822108B2 (en) 2012-01-13 2017-11-21 Rutgers, The State University Of New Jersey Antimicrobial agents
WO2013142712A1 (en) 2012-03-21 2013-09-26 Rutgers, The State University Of New Jersey Antimicrobial agents
WO2013160435A1 (en) 2012-04-27 2013-10-31 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
IN2014MN02358A (pt) 2012-04-27 2015-08-14 Janssen Pharmaceutica Nv
CA2888485C (en) 2012-10-16 2021-01-26 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of ror.gamma.t
AU2013331493A1 (en) 2012-10-16 2015-04-09 Janssen Pharmaceutica Nv Heteroaryl linked quinolinyl modulators of RORyt
ME02794B (me) 2012-10-16 2018-01-20 Janssen Pharmaceutica Nv Metilen vezani hinolinil modulatori ror-gama-t
US9403816B2 (en) 2013-10-15 2016-08-02 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of RORγt
US10555941B2 (en) 2013-10-15 2020-02-11 Janssen Pharmaceutica Nv Alkyl linked quinolinyl modulators of RORγt
US9284308B2 (en) 2013-10-15 2016-03-15 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of RORγt
US9221804B2 (en) 2013-10-15 2015-12-29 Janssen Pharmaceutica Nv Secondary alcohol quinolinyl modulators of RORγt
US9328095B2 (en) 2013-10-15 2016-05-03 Janssen Pharmaceutica Nv Heteroaryl linked quinolinyl modulators of RORgammat
BR112016008215A2 (pt) 2013-10-15 2017-09-26 Janssen Pharmaceutica Nv moduladores de quinolinila ligados por alquila de roryt
ES2742843T3 (es) * 2013-10-15 2020-02-17 Janssen Pharmaceutica Nv Moduladores de quinolinilo de ROR(gamma)t
US9458150B2 (en) 2013-11-08 2016-10-04 Rutgers, The State University Of New Jersey Antimicrobial agents
EP3419967A4 (en) 2016-02-25 2019-10-16 Taxis Pharmaceuticals, Inc. METHODS AND INTERMEDIARIES FOR SYNTHESIS
US10774093B2 (en) 2017-03-30 2020-09-15 Taxis Pharmaceuticals, Inc. Synthetic processes and synthetic intermediates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2270123A1 (en) * 1996-10-28 1998-05-07 Department Of The Army, U.S. Government Compounds, compositions and methods for treating antibiotic-resistant infections
US6103905A (en) 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6172084B1 (en) * 1997-06-19 2001-01-09 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
AU2717899A (en) * 1998-01-26 1999-08-09 Smithkline Beecham Plc Quinoline derivatives as antibacterials
AP2421A (en) * 2002-07-25 2012-06-08 Janssen Pharmaceutica Nl Quinoline derivatives and their use as mycobacterial inhibitors.
ATE392423T1 (de) * 2004-01-23 2008-05-15 Janssen Pharmaceutica Nv Substituierte chinoline und deren verwendung als inhibitoren von mycobakterien

Also Published As

Publication number Publication date
ATE395336T1 (de) 2008-05-15
CN1910154A (zh) 2007-02-07
EP1713776A1 (en) 2006-10-25
WO2005075428A1 (en) 2005-08-18
HK1099297A1 (en) 2007-08-10
UA83875C2 (ru) 2008-08-26
AU2005210036A1 (en) 2005-08-18
NO337253B1 (no) 2016-02-22
KR20070004597A (ko) 2007-01-09
US20070299106A1 (en) 2007-12-27
DE602005006744D1 (de) 2008-06-26
AU2005210036B2 (en) 2010-12-23
IL177101A (en) 2012-01-31
NO20063821L (no) 2006-08-28
ES2306098T3 (es) 2008-11-01
EA200601391A1 (ru) 2006-12-29
EA011572B9 (ru) 2018-01-31
CN1910154B (zh) 2011-08-17
MXPA06008596A (es) 2006-08-28
JP2007519687A (ja) 2007-07-19
US7790894B2 (en) 2010-09-07
IL177101A0 (en) 2006-12-10
AP2321A (en) 2011-11-16
NZ547614A (en) 2009-04-30
CA2554049C (en) 2012-12-18
AP2006003705A0 (en) 2006-08-31
EA011572B1 (ru) 2009-04-28
EP1713776B1 (en) 2008-05-14
ZA200606291B (en) 2008-02-27
KR101160183B1 (ko) 2012-06-26
CA2554049A1 (en) 2005-08-18
JP4919810B2 (ja) 2012-04-18

Similar Documents

Publication Publication Date Title
BRPI0507312A (pt) derivados de quinolina para uso como inibidores micobacterianos
NO20080129L (no) Fremgangsmate for fremstilling av dihydrokinazoliner
TW200714589A (en) Phenylacetamides suitable as protein kinase inhibitors
MX2009008798A (es) Derivados de iminipiridina y sus usos como microbicidas.
MY161991A (en) Proteasome inhibitors
PT1902037E (pt) 2,4-diamino-pirimidinas como inibidores de aurora
EA200970207A1 (ru) Соединения пиридо[2,3-d]пиримидинона и их применение в качестве pi3 ингибиторов
BR112012022513A2 (pt) derivados de piperidin-4-il azetidina como inibidores de jak1
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
EA200801428A1 (ru) Производные пиридиазинона для лечения опухолей
MY140514A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
UA102858C2 (ru) Производные пиридино-пиридинонов, способ их получения и применения в терапии
SE0403171D0 (sv) New compounds
ECSP088700A (es) Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1
TW200630374A (en) Thiazolyldihydroindazoles
MX2009013515A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica.
CR9182A (es) Derivado de quinolina, su uso, preparacion y medicamento que lo contiene
MX372721B (es) Ánalogos halogenados de agentes antifi-broticos.
ATE517873T1 (de) 6-oxo-1,6-dihydropyrimidin-2-yle bei der behandlung proliferativer krankheiten
SG158091A1 (en) Imidazoazepinone compounds
ECSP099506A (es) Derivados de 2-quinolinona y 2 quinoxalinona y su utilización como agentes anti bacterianos
DOP2005000010A (es) Inhibidores de quinasa
DE602006009789D1 (de) Acetylenderivate
EA200901504A1 (ru) Производные пиразолона, как ингибиторы pde4
ECSP11011053A (es) [4-(1-amino-etil)-ciclohexil]-metil-aminas como antibacterianos

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL